Literature DB >> 31359766

C1q/TNF-Related Proteins, HIV and HIV-Associated Factors, and Cardiometabolic Phenotypes in Middle-Aged Women.

Michal Kasher Meron1, Shuo Xu2, Marshall J Glesby3,4, Qibin Qi2, David B Hanna2, Kathryn Anastos1,2, Robert C Kaplan2, Jorge R Kizer1,2,5,6,7.   

Abstract

C1q/tumor necrosis factor (TNF)-related proteins (CTRPs) have been linked to energy homeostasis and vascular health. People with HIV are susceptible to cardiometabolic disease, but the contributions of different CTRPs are unknown. We investigated the associations of HIV and related factors with serum CTRPs, and CTRPs' relationships with cardiometabolic phenotypes. This involved a cross-sectional analysis of participants in the Women's Interagency HIV Study aged ≥35 with (n = 209) and without (n = 92) HIV who underwent carotid ultrasound in 2004-2005 and had stored serum available for measurement of total adiponectin and CTRPs 1, 3, 5, and 9. The Benjamini/Hochberg procedure was used to control the study-wide false-positive rate. HIV-positive women had significantly higher adiponectin than HIV-negative women after adjustment for sociodemographic, behavioral, and clinical variables [beta = 0.29 (95% confidence interval 0.11-0.47)]. Among HIV-positive women, lower CD4 count was associated with higher adiponectin and history of AIDS with higher CTRP9, but these were only nominally significant. There was no relationship between HIV status and CTRP 1, 3, or 5, nor was antiretroviral therapy or viral load associated with any CTRP. In the entire cohort, higher adiponectin was associated with significantly lower fasting glucose and insulin resistance, while higher CTRP5 [beta = -0.02 (-0.033 to -0.007)]-and, at a nominal level, CTRPs 1 and 3-was associated with significantly lower carotid intima-media thickness. In conclusion, in this sample of middle-aged women, HIV serostatus was positively associated with adiponectin, but not CTRPs. In turn, serum adiponectin was inversely associated with glucose dysregulation, whereas CTRP5 was inversely associated with carotid intima-media thickness. Further research is needed to determine CTRPs' role in atherosclerosis.

Entities:  

Keywords:  CTRP; HIV; adiponectin; cardiovascular disease; glycemia; insulin resistance

Year:  2019        PMID: 31359766      PMCID: PMC6862952          DOI: 10.1089/AID.2019.0099

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  49 in total

1.  C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.

Authors:  Qijun Zheng; Yuexing Yuan; Wei Yi; Wayne Bond Lau; Yajing Wang; Xiaoliang Wang; Yang Sun; Bernard L Lopez; Theodore A Christopher; Jonathan M Peterson; G William Wong; Shiqiang Yu; Dinghua Yi; Xin-Liang Ma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

3.  C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue.

Authors:  Andrea Kopp; Margarita Bala; Christa Buechler; Werner Falk; Philipp Gross; Markus Neumeier; Jürgen Schölmerich; Andreas Schäffler
Journal:  Endocrinology       Date:  2010-08-25       Impact factor: 4.736

4.  Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.

Authors:  Carol L Addy; Alina Gavrila; Sotirios Tsiodras; Kimberly Brodovicz; Adolf W Karchmer; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

5.  Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study.

Authors:  Jorge R Kizer; David Benkeser; Alice M Arnold; Kenneth J Mukamal; Joachim H Ix; Susan J Zieman; David S Siscovick; Russell P Tracy; Christos S Mantzoros; Christopher R Defilippi; Anne B Newman; Luc Djousse
Journal:  Circulation       Date:  2012-11-16       Impact factor: 29.690

Review 6.  Diabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus.

Authors:  Colleen Hadigan; Sarah Kattakuzhy
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

7.  Loss of CTRP5 improves insulin action and hepatic steatosis.

Authors:  Xia Lei; Susana Rodriguez; Pia S Petersen; Marcus M Seldin; Caitlyn E Bowman; Michael J Wolfgang; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-03       Impact factor: 4.310

8.  C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis.

Authors:  Lin Lu; Rui Yan Zhang; Xiao Qun Wang; Zhu Hui Liu; Ying Shen; Feng Hua Ding; Hua Meng; Ling Jie Wang; Xiao Xiang Yan; Ke Yang; Hai Bo Wang; Li Jin Pu; Qi Zhang; Qiu Jing Chen; Raffaele De Caterina; Wei Feng Shen
Journal:  Eur Heart J       Date:  2015-12-24       Impact factor: 29.983

9.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

10.  Burden of Cardiovascular Disease among Multi-Racial and Ethnic Populations in the United States: an Update from the National Health Interview Surveys.

Authors:  Longjian Liu; Ana E Núṅez; Yuan An; Hui Liu; Ming Chen; Jixiang Ma; Edgar Y Chou; Zhengming Chen; Howard J Eisen
Journal:  Front Cardiovasc Med       Date:  2014-11-10
View more
  2 in total

1.  HIV, hepatitis C virus and risk of new-onset left ventricular dysfunction in women.

Authors:  Sanyog G Shitole; Jason M Lazar; David B Hanna; Ryung S Kim; Kathryn Anastos; Mario J Garcia; Phyllis C Tien; João A C Lima; Robert C Kaplan; Jorge R Kizer
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.632

Review 2.  C1q/Tumor Necrosis Factor-Related Protein 9: Basics and Therapeutic Potentials.

Authors:  Hua Guan; Yanli Wang; Xiangyu Li; Aoqi Xiang; Fengwei Guo; Jianglin Fan; Qi Yu
Journal:  Front Physiol       Date:  2022-03-18       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.